ARCHIVES

In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced

This article is from The Cancer Letter archive.

Vol. 16 No. 31 | August 3, 1990

Download PDF Visit The Full Archive

Related Articles

Senate Committee Approves $1.74 Billion for NCI, Seeks Activation of Dietary Intervention Trial

October 19, 1990

Decline In Breast Cancer Death Explained By Screening, Adjuvant Therapy, Study Finds

November 25, 2005

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

March 8, 2002

Cancer Policy: Board Plans Paper On Tobacco Control

June 13, 1997

Women’s Health Was ‘Highest Priority’ Of House Committee

July 31, 1992